SynthesisFrontiers in oncology2025

CD20×CD3 bispecific antibody achieved significant efficacy in patients with large B-cell lymphoma relapsing after or refractory to CAR-T therapy: a systematic review and meta-analysis.

Jing Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.